Abstract:Extracts of fermented barley with Lactiplantibacillus plantarumdy-1 (LFBE) have been reported to exert antiobesity activity in vivo and in vitro. However, whether it worked in clinical trials remained uncovered. In the current study, we conducted a single-blind experiment by enrolling on some obese adult humans with hyperlipemia to test the effects of products containing LFBE (No. ChiCTR1800019614 by the Chinese Clinical Trial Registry). Results indicated that LFBE intervention could ameliorate the symptoms of the obese, characterized by the decrease of body fat percentage, visceral fat area, and serum lipid levels. More interestingly, products containing the beta-glucan ingredients had similar antiobesity effects. 16S rRNA sequencing revealed that LFBE modulated the community structure of the gut microbiota of the obese adults as shown by the diversity analysis. For gut microbiota composition, LFBE significantly increased the Bacteroides genus while decreasing Streptococcus and Haemophilus genus. At the species level, beneficial microorganisms such as Bifidobacterium_longum_subsp_longum, Alistipes_sp_AL-1, Bacteroides_plebeius, and Bacteroides_vulgatus were enriched by LFBE, which was different from the effects of beta-glucan. Furthermore, Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis indicated that LFBE particularly regulated the steroid biosynthesis and hypertrophic cardiomyopathy pathways. Furthermore, correlation analysis suggested that body fat percentage and visceral fat area were significantly positively correlated with Desulfovibrio and Sutterella, the basal metabolic rate was negatively correlated with Haemophilus, and fasting blood glucose was positively correlated with Dialister. In all, this clinical study demonstrated the antiobesity function of LFBE in humans, probably via its interactions with the gut microbiota, and LFBE could be developed as a prebiotic ingredient with antiobesity effects for a healthy diet. This trial is registered with ChiCTR1800019614.

Fermented Barley Extracts with Lactobacillus Plantarum Dy-1 Rich in Vanillic Acid Modulate Glucose Consumption in Human HepG2 Cells.

Metabolomics Reveal the Regulatory Effect of Polysaccharides from Fermented Barley Bran Extract on Lipid Accumulation in HepG2 Cells

Anti-obesity Action of Fermented Barley Extracts with Lactobacillus Plantarum Dy-1 and Associated MicroRNA Expression in High-fat Diet-induced Obese Rats

Fermented Barley Extracts with Lactobacillus Plantarum Dy-1 Decreased Fat Accumulation of Caenorhabditis Elegans in a Daf-2-dependent Mechanism.

Fermented Barley Extracts with Lactobacillus Plantarum Dy-1 Changes Serum Metabolomic Profiles in Rats with High-Fat Diet-Induced Obesity.

Fermented barley extracts with Lactobacillus plantarum dy-1 decreased fat accumulation of Caenorhabditis elegans in a daf-2-dependent mechanism

Inhibitory Effect of Fermented Selected Barley Extracts with Lactobacillus Plantarum Dy-1 on the Proliferation of Human HT-29 Cells

Metabolomics reveals the effects of<i> Lactiplantibacillus</i><i> plantarum</i> dy-1 fermentation on the lipid-lowering capacity of barley 13-glucans in an<i> in</i><i> vitro</i> model of gut-liver axis

Lactobacillus Plantarum Dy-1 Fermented Barley Extraction Activates White Adipocyte Browning in High-Fat Diet-Induced Obese Rats.

Metabolomics Reveals the Effects of Lactiplantibacillus Plantarum Dy-1 Fermentation on the Lipid-Lowering Capacity of Barley Β-Glucans in an in Vitro Model of Gut-Liver Axis.

Antiobesity Effect of Lactiplantibacillus Plantarum Fermented Barley Extracts Via the Interactions with Gut Microbiota of the Obese Adult Humans

Transcriptomics Reveals the Anti-Obesity Mechanism of Lactobacillus Plantarum Fermented Barley Extract

Fermented Barley Β‐glucan Regulates Fat Deposition in Caenorhabditis Elegans

Dietary Supplementation with Lactobacillus Plantarum Dy-1 Fermented Barley Suppresses Body Weight Gain in High-Fat Diet-Induced Obese Rats.

Effect Oflactobacillus Plantarumfermented Barley On Plasma Glycolipids And Insulin Sensitivity In Subjects With Metabolic Syndrome

Influences of Lactiplantibacillus Plantarum and Saccharomyces Cerevisiae Fermentation on the Nutritional Components, Flavor Property and Lipid-Lowering Effect of Highland Barley

Supplementation of Fermented Barley Extracts with Lactobacillus Plantarum Dy-1 Inhibits Obesity Via a UCP1-dependent Mechanism.

Phytochemical Profiles and Antioxidant Activity of Fermented Barley with Lactiplantibacillus Plantarum Dy-1

Anti-α-Glucosidase Activities and Bioactive Components of Tibetan Hull-Less Barley Bran Extracts

Lactiplantibacillus plantarum MG4296 and Lacticaseibacillus paracasei MG5012 Ameliorates Insulin Resistance in Palmitic Acid-Induced HepG2 Cells and High Fat Diet-Induced Mice

Barley Protein LFBEP-C1 from Lactiplantibacillus plantarum dy-1 Fermented Barley Extracts by Inhibiting Lipid Accumulation in a Caenorhabditis elegans Model